M2i Life Sciences

ActiveOn the Biological inputs Radar · not ranked

Synthesises and formulates insect pheromones for mating-disruption products that protect orchards, vineyards and field crops against pests, alongside fine chemicals.

Food & agriculture›Biological inputs m2i-lifesciences.com

HQFrance

Last roundSeries C · Sep 2019

Why M2i Life Sciences is not ranked yet

How the Radar works →

The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. M2i Life Sciences enters the ranking once its public data is sufficient for the AI to estimate it. Next Biological inputs worldwide edition: 12 Feb 2027.

Funding history

Date	Round	Amount	Type	Investors
Sep 2019	Series C	USD 66M	Equity	Creadev, France 2i

EUR 60M; no later round found.

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Biological inputs · worldwide	Radar	—	Edition 0 · Oct 2026	12 Feb 2027

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of M2i Life Sciences as a PDF. It must answer at least one of these four questions, and stick to them:

ValuationWhat is M2i Life Sciences worth?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back M2i Life Sciences whether or not it has agreed: your intention joins the pool on M2i Life Sciences, passed to the local partner once it reaches critical mass. Declaring an intention does not mean this company is raising funds.

Back M2i Life Sciences Or back food & agriculture in France

Pool on M2i Life SciencesBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until a deal process opens. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run M2i Life Sciences?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Pappers (French company registry)Planned

Read by the AI at the next edition.

Comparable companies in biological inputs

Full biological inputs ranking →

BioFirst#1BelgiumUnicorn Pivot Bio#2United StatesHundreds of M$Sound Agriculture#3United StatesHundreds of M$Vestaron#4United StatesHundreds of M$

Investors in M2i Life Sciences: Creadev · France 2i

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.